drugset / Trial / NCT03954990

Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity

NCT03954990

Phase 1 Terminated 75 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Bacterial vaginosis (BV) is the most common cause of vaginal discharge among repro-ductive aged women. It is been linked to adverse maternal and neonatal outcomes. Our objective is to evaluate if the use of a single dose of metronidazole in women with BV at time of delivery reduces infectious morbidities

Timeline

Start
2019-10-11
Primary completion
2022-09-26
Completion
2022-09-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 2 g Oral

Indications